Clinicopathologic and immunohistochemical study of early colorectal cancer with liver metastases

被引:16
|
作者
Okano, K [1 ]
Shimoda, T [1 ]
Matsumura, Y [1 ]
机构
[1] Natl Canc Hosp, Dept Surg Oncol, Tokyo, Japan
关键词
early colorectal cancer; liver metastases; p53; CD44; mucin;
D O I
10.1007/s005350050270
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Seven (3.3%) of 213 patients who underwent surgery for early colorectal cancer (invasion limited to no deeper than the submucosa) at the National Cancer Center Hospital, Tokyo, between 1986 and 1995 had synchronous (2 patients) or metachronous (5 patients) liver metastases. The average period from surgical resection of the primary colorectal cancer to the diagnosis of liver metastases was 25 months (range, 0-52 months). The clinicopathologic and immunohistochemical features of the primary lesions in these patients were compared with these features in the lesions in consecutive patients with early colorectal cancer who had no evidence of liver metastases within at least 5 years after colorectal resection. Venous invasion was more frequent in the primary lesions with liver metastases than in those without liver metastases (57% vs 0%; P = 0.0035), Expression of p53 and CD44v9 was more frequent in the primary lesions with liver metastases (71% and 100%) than in those without metastases (56% and 72%). In contrast, MUC2 expression was more frequent in the primary lesions without liver metastases (72%) than in those with metastases (43%). Venous invasion is considered to be closely related to liver metastasis, and the immunohistochemical expression of p53 and CD44v9 provides useful information for identifying those patients with early colorectal cancer who have a high risk of developing liver metastases.
引用
收藏
页码:334 / 340
页数:7
相关论文
共 50 条
  • [1] Clinicopathologic and immunohistochemical study of early colorectal cancer with liver metastases
    Keiichi Okano
    Tadakazu Shimoda
    Yasuhiro Matsumura
    Journal of Gastroenterology, 1999, 34 : 334 - 340
  • [2] Immunohistochemical study of colorectal cancer liver metastases: the immune/inflammatory infiltrate
    Giusca, Simona Eliza
    Zugun, Fl. Eloae
    Tarcoveanu, E.
    Carasevici, E.
    Amalinei, Cornelia
    Caruntu, Irina-Draga
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2010, 51 (01): : 73 - 79
  • [3] Clinicopathologic and immunohistochemical profile of ovarian metastases from colorectal carcinoma
    Kir, Gozde
    Gurbuz, Ayse
    Karateke, Ates
    Kir, Mustafa
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2010, 2 (04): : 109 - 116
  • [4] Liver metastases of colorectal cancer
    Hoffmann, R. -T.
    RADIOLOGE, 2017, 57 (02): : 90 - 96
  • [5] Liver metastases in colorectal cancer
    Joan Figueras
    Jaume Torras
    Teresa Serrano
    Revista de Oncología, 2001, 3 (5): : 278 - 279
  • [6] Immunohistochemical detection of occult colorectal cancer Metastases
    Spasevska, L
    Janevska, V
    Janevski, V
    Kostadinova, S
    Jovanovic, R
    II INTERCONTINENTAL CONGRESS OF PATHOLOGY, 2004, : 31 - 34
  • [7] A Retrospective Study on the Role of Metformin in Colorectal Cancer Liver Metastases
    Rada, Miran
    Krzywon, Lucyna
    Petrillo, Stephanie
    Lazaris, Anthoula
    Metrakos, Peter
    BIOMEDICINES, 2023, 11 (03)
  • [8] Liver resection for colorectal cancer metastases
    Gallinger, S.
    Biagi, J. J.
    Fletcher, G. G.
    Nhan, C.
    Ruo, L.
    McLeod, R. S.
    CURRENT ONCOLOGY, 2013, 20 (03) : E255 - E265
  • [9] Management of Colorectal Cancer Liver Metastases
    Durden, Jakob A.
    Ziogas, Ioannis A.
    Moris, Dimitrios P.
    Gleisner, Ana L.
    CANCERS, 2024, 16 (02)
  • [10] Treatment of liver metastases of colorectal cancer
    van de Velde, CJH
    ANNALS OF ONCOLOGY, 2005, 16 : 144 - 149